Orexigen Therapeutics Inc entered the industry of in 2003 and has grown to employ 1 to 4 people, generating an annual revenue of Unknown. The NAICS classifies this business under the code 5417114, which describes it as a . For further clarification, the SIC classifies this business under the code 2834 and described it as a . The business provides service to the BOTH market.
To acquire more information, please contact Michael Narachi, Chief Executive Officer by calling (858) 875-8600 during business hours. You can also write to the business’ Headquarters at 3344 North Torrey Pines Court # 200, La Jolla, California CA 92037. You can also visit the company’s website at orexigen.com. View this business’ social media profiles on Twitter or on Facebbok .
| Company: | Orexigen Therapeutics Inc |
| Representative: | Michael Narachi, Chief Executive Officer |
| Place of Business: | 3344 North Torrey Pines Court # 200, La Jolla, CA 92037 |
| Contact Number: | (858) 875-8600 |
| Website: | orexigen.com |
| Type of Service: | |
| SIC Number: | 2834 |
| NAICS Number: | 5417114 |
| Locality: | Headquarters |
| Market Type: | B2B & B2C |
| Began: | 2003 |
| Income/Year: | Unknown |
| Laborers: | 1 to 4 |
| Share This Company: |
Orexigen Therapeutics Inc is a company operating from San Diego, California providing professional and relevant BOTH variables. It was founded in 2003 and registered with the SIC code 2834 as , and with the NAICS code 5417114 as .
With a current employee count of 1 to 4, Orexigen Therapeutics Inc has gone to report making Unknown per annum on its journey towards growth. This company invites you to contact its representative Michael Narachi, Chief Executive Officer at (858) 875-8600 for related queries, or to locate its Headquarters using the coordinates 32.89303,-117.24216.
The Headquarters can also be found at the street address 3344 North Torrey Pines Court # 200 in La Jolla, California 92037 and can be engaged online through the company website at orexigen.com, the company Twitter , and Facebook page .